Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC
Go back to Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC| AGENUS (NASDAQ: AGEN) | Delayed: 3.04 +0.04 (1.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.00 | 52 Week High | $7.49 | |||
| Open | $2.99 | 52 Week Low | $2.61 | |||
| Day High | $3.10 | P/E | N/A | |||
| Day Low | $2.98 | EPS | $-1.10 | |||
| Volume | 476,300 | |||||
| (NASDAQ: INKT) | Delayed: 12.25 +0.11 (0.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.14 | 52 Week High | $ | |||
| Open | $12.33 | 52 Week Low | $ | |||
| Day High | $12.51 | P/E | N/A | |||
| Day Low | $12.01 | EPS | $ | |||
| Volume | 19,823 | |||||
